Paid Clinical Trials Pennsylvania

Discover 3,011 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 3,011

ALS20-101ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia

Recruiting

PHASE1

PHASE2

Sponsor:

Children's Hospital of Philadelphia

Location:

Philadelphia PA

Code:

NCT06364774

Conditions

Beta-Thalassemia

Eligibility Criteria

Sex: All

Age: 18 - 35

Healthy Volunteers: Not accepted

Interventions

ALS20

Virtual RealityEfficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain

Recruiting

Sponsor:

Albert Einstein Healthcare Network

Location:

Elkins Park PA, Philadelphia PA, Seattle WA

Code:

NCT05296265

Conditions

Phantom Limb Pain

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

VR treatment for phantom limb pain

CryoablationCryoablation for Monomorphic Ventricular Tachycardia

Recruiting

Sponsor:

Adagio Medical

Location:

Baltimore MD, Philadelphia PA, Staten Island NY, New York NYshow 9 more

Code:

NCT05675865

Conditions

Sustained VT

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

cryoablation procedure

IanalumabTwo-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease

Recruiting

PHASE2

Sponsor:

Novartis Pharmaceuticals

Location:

Duncansville PA, Middleburg Heights OH, Grand Blanc MI, Trois Rivieresshow 14 more

Code:

NCT06293365

Conditions

Sjögrens Disease

Systemic Lupus Erythematosus

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

VAY736 1ml PFS

VAY736 2 ml PFS

VAY736 2ml AI

RLS-0071Safety, PK and PD Relationships of RLS-0071 in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Recruiting

PHASE2

Sponsor:

ReAlta Life Sciences, Inc.

Location:

Glen Burnie MD, Philadelphia PA, Saint Petersburg FL, Omaha NE

Code:

NCT06175065

Conditions

Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Eligibility Criteria

Sex: All

Age: 30+

Healthy Volunteers: Not accepted

Interventions

RLS-0071

Placebo

PovorcitinibA Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

Recruiting

PHASE3

Sponsor:

Incyte Corporation

Location:

Baltimore MD, Rockville MD, Philadelphia PA, Yardley PAshow 47 more

Code:

NCT06516965

Conditions

Prurigo Nodularis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Povorcitinib

Placebo

Nivolumab & TovorafenibNivolumab and Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

Recruiting

PHASE2

Sponsor:

Sabine Mueller, MD, PhD

Location:

Baltimore MD, Philadelphia PA, New York NY, Durham NCshow 11 more

Code:

NCT05465174

Conditions

Craniopharyngioma, Child

Craniopharyngioma

Recurrent Craniopharyngioma

Eligibility Criteria

Sex: All

Age: 1 - 39

Healthy Volunteers: Not accepted

Interventions

Nivolumab

Tovorafenib

LY3209590A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus

Recruiting

PHASE1

Sponsor:

Eli Lilly and Company

Location:

Baltimore MD, Philadelphia PA, New York NY, Buffalo NYshow 7 more

Code:

NCT06362265

Conditions

Type 2 Diabetes Mellitus

Eligibility Criteria

Sex: All

Age: 10 - 17

Healthy Volunteers: Not accepted

Interventions

LY3209590

ONC206ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

Recruiting

PHASE1

Sponsor:

Sabine Mueller, MD, PhD

Location:

Philadelphia PA, Ann Arbor MI, Atlanta GA, San Francisco CA

Code:

NCT04732065

Conditions

Diffuse Midline Glioma (DMG)

Glioblastoma

Recurrent Ependymoma

Recurrent Malignant Central Nervous System Neoplasm

Spinal Cord Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

ONC206

Standard of Care Radiation Therapy

Optional Proton (1H) MR spectroscopy (MRS)

ATG-101A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas

Recruiting

PHASE1

Sponsor:

Antengene Biologics Limited

Location:

Philadelphia PA, Saint Louis MO, San Francisco CA

Code:

NCT04986865

Conditions

Advanced Solid Tumor

Metastatic Solid Tumor

Mature B-cell Non-Hodgkin Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ATG-101

Popular cities in Pennsylvania

Pittsburgh Allentown Philadelphia